Main characteristics of included studies
Authors, year | Country, year of participants’ enrolment | Study design | Affected/Non-affected | Gestational age at assessment | Type of pregnancy | Parity | Birthweight curve |
Outcome: SGA <5th centile | |||||||
Costet et al, 201231 | France, 2002–2006 (PELAGIE cohort) | Nested case–control | 134/399 | 11 weeks | Single pregnancy | Nulliparous and parous women, unclear proportions | Customised curve |
Ertl et al, 201232 | UK* | Nested case–control | 150/1000 | 11+0–13+6 weeks | Unclear | 55.3% nulliparous in SGA group, 48.1% nulliparous in control group | Population-based charts |
Outcome: SGA <10th centile | |||||||
Grandone et al, 200633 | Italy* | Cohort | 31/393 | 17.1±1.2 weeks† (mean) | Single pregnancy; no maternal pre-existing conditions | Unclear | Population-based charts |
van Eijsden et al, 200839 | The Netherlands, 2003–2004 (ABCD study) | Cohort | 429/3275 | 13.5±3.3 weeks (mean) | Term deliveries, no diabetes or hypertension | 57.6% nulliparous | Population-based charts |
Horgan et al, 201117 | Australia, 2008–2011 (SCOPE cohort) | Nested case–control | 40/40 | 14–16 weeks | Single pregnancy; no other pregnancy complications | Nulliparous | Customised curve |
Gernand et al, 201340 | USA, 1959–1965 (Collaborative Perinatal Project) | Nested case–control | 395/1751 | ≤26 weeks | Single pregnancy; term deliveries | Parous women | Population-based charts |
Sulek et al, 201418 | Singapore* (GUSTO study) | Nested case–control | 41/42 | 26–28 weeks | Single pregnancy; term deliveries; no maternal pre-existing conditions | Nulliparous and parous women, unclear proportions | Population-based charts |
Choi et al, 201634 | South Korea, 2012–2013 | Cohort | 39/217 | First, second or third trimester | Single pregnancies | Nulliparous and parous women, unclear proportions | Population-based charts |
Kiely et al, 201635 | Ireland, 2008–2011 (SCOPE cohort) | Cohort | 190/1578 | 14–16 weeks | Single pregnancy; no maternal pre-existing conditions | Nulliparous | Customised curve |
Ong et al, 201637 | Singapore* (GUSTO study) | Cohort | 83/827 | 26–28 weeks | Single pregnancy; no maternal chronic illness | 43.5% nulliparous | Population-based charts |
Wang et al, 201636 | Taiwan, 2000–2001 (Taiwan Maternal and Infant Cohort Study) | Cohort | 35/188 | Third trimester | Unclear; term deliveries | 48% nulliparous | Population-based charts |
Delplancke et al, 201828 | New Zealand* | Cohort | 20/73 | 34–37 weeks | Unclear; term deliveries | Unclear | Customised curve |
Luthra et al, 201838 | USA, 2010–2012 (TIDES study) | Nested case–control | 53/106 | First and second trimester | Single pregnancies; term deliveries | 60% nulliparous | Customised curve |
Gong et al, 201841 | UK, 2008–2012 (POP study) | Nested case–control | 162/259 | 36 weeks | Single pregnancies; term deliveries | Nulliparous | Customised curve |
Morillon et al, 201842 | 2008–2011 (SCOPE study) | Nested case–control | 40/40 | 20 weeks | Single pregnancies | Nulliparous | Customised curve |
*Unclear period of participant recruitment.
†Mean for all study participants.
ABCD, Adolescent Brain Cognitive Development; GUSTO, Growing Up in Singapore Towards healthy Outcomes; PELAGIE, Étude Longitudinale sur les Anomalies de la Grossesse, l’Infertilité et l’Enfance; POP, Pregnancy Outcome Prediction; SCOPE, Screening of Pregnancy Endpoints; SGA, small for gestational age; TIDES, Tackling Inequalities and Discrimination Experiences in health Services.